Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N5HJ
|
||||
Former ID |
DAP001374
|
||||
Drug Name |
Enalaprilat
|
||||
Synonyms |
EAL; Enalaprilate; Enalaprilatum; ENALAPRILAT INHIBITOR; Enalapril acid; Enalapril diacid; Enalaprilat anhydrous; Enalaprilic acid; Enalprilat hydrate; Enalprilate hydrate; Enalaprilat (USP); MK-422; Renitec (TN); Vasotec (TN); Vasotec I.V.; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline; N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2); (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid; (2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate; 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE; 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihypertensive Agents
|
||||
Company |
Merck & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H24N2O5
|
||||
InChI |
InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1
|
||||
InChIKey |
LZFZMUMEGBBDTC-QEJZJMRPSA-N
|
||||
CAS Number |
CAS 76420-72-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
13885, 7887268, 11688562, 14876097, 14900718, 26719866, 26758015, 39459536, 46386741, 49681611, 50070755, 50466382, 92308386, 92308980, 93166910, 93311012, 93577953, 99313641, 103179234, 104253291, 114004069, 118313442, 121362057, 124659029, 124757412, 124800027, 125164216, 126650398, 128562671, 131325846, 134221872, 135012534, 137024395, 143297080, 144076246, 151979549, 152031989, 160661062, 160846356, 162176890, 162262134, 163564990, 164786777, 165698333, 172080415, 172913628, 175266379, 176484234, 176484707, 178102950
|
||||
Target and Pathway | |||||
Target(s) | Angiotensin-converting enzyme | Target Info | Inhibitor | [535379] | |
PathWhiz Pathway | Angiotensin Metabolism | ||||
References | |||||
Ref 536361 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. | ||||
Ref 541478 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6332). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.